A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review

According to a story from Morningstar, the company Alexion Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) has agreed to review their Biologics Licensing Application for their…

Continue Reading A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review
FDA Grants Orphan Drug Designation to Onspira Therapeutics’ Investigational Interleukin-1 Receptor Antagonist for the Treatment of Bronchiolitis Obliterans
InspiredImages / Pixabay

FDA Grants Orphan Drug Designation to Onspira Therapeutics’ Investigational Interleukin-1 Receptor Antagonist for the Treatment of Bronchiolitis Obliterans

According to a story from Business Wire, the biopharmaceutical company Onspira Therapeutics recently announced that its investigational therapy OSP-101 was recently granted Orphan Drug designation by the US Food and…

Continue Reading FDA Grants Orphan Drug Designation to Onspira Therapeutics’ Investigational Interleukin-1 Receptor Antagonist for the Treatment of Bronchiolitis Obliterans
What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors
IADE-Michoko / Pixabay

What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors

On August 16th, 2018, Aretha Franklin, the "Queen of Soul," passed away at age 76. Aretha will be immortalized for generations because of the success of her classic soul ballads…

Continue Reading What Killed Aretha Franklin? An In-Depth Look at Pancreatic Neuroendocrine Tumors